You are currently viewing the summary.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Summary
A controlled clinical trial published in January 2013 has shown that fecal transplants can help cure recurrent infections with Clostridium difficile. Researchers think patients with other diseases, too, may benefit from the procedure, but much more study is needed. Meanwhile, scientists are trying to understand the underlying mechanisms and hoping that, in the future, they will be able to transplant selected bacterial strains instead of human stool.
-
↵* Jop de Vrieze is a science writer in Amsterdam.
